文献速递糖尿病

2型糖尿病疾病修饰结局:改良德尔菲法核心结局集

Disease modification outcomes in type 2 diabetes: a modified Delphi.
PubMed 文献 · Lancet Diabetes Endocrinol · 2026-09-29

该研究依据COMET指南开展改良德尔菲法,由国际多学科指导组从文献中筛选候选结局,经两轮德尔菲调查(第一轮n=233,第二轮n=79)在11个域内就35项结局达成共识,形成2型糖尿病疾病修饰核心结局集,以支持试验结局选择、跨试验一致性与干预比较。

要点

  • 形成覆盖11个域、35项结局的2型糖尿病疾病修饰核心结局集
  • 共识经两轮德尔菲调查达成,参与方包括医护人员、研究者与患者
  • 目的是统一试验结局选择,便于比较不同干预对疾病轨迹的影响

核心结论

  • 通过改良德尔菲法建立2型糖尿病疾病修饰核心结局集,涵盖11个域共35项结局,用于支持结局选择、试验间一致性与干预比较。

研究设计与样本

  • 依据COMET指南开展改良德尔菲法,候选结局来自文献并由国际多学科指导组(含临床医生、研究者与2型糖尿病患者)修订。
  • 两轮德尔菲调查纳入医护人员、研究者与患者,第一轮n=233,第二轮n=79。

主要发现

  • 两轮德尔菲调查后,在11个域内对35项结局达成共识。
  • 原文指出2型糖尿病具有异质性和进展性,传统管理聚焦血糖控制与心血管危险因素,而非改变长期疾病轨迹。
  • 原文指出进展与并发症可能可修饰,但缺乏疾病修饰的核心结局集限制了试验设计与干预比较。

关键数值与推荐

  • 共识结局数量:35项;覆盖域:11个;德尔菲轮次:两轮;第一轮n=233,第二轮n=79。

临床怎么用

  • 该核心结局集可用于2型糖尿病疾病修饰相关试验的结局选择,促进跨试验一致性并支持干预间比较。
  • 可用于评估疾病修饰策略,但原文未给出具体推荐条款或临床应用路径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Type 2 diabetes is a heterogeneous, progressive chronic condition for which management has traditionally focused on glycaemic control and cardiovascular risk factors, rather than focusing on altering long-term disease trajectory. Increasing evidence indicates that progression and complications might be modifiable, but the absence of a core outcome set for disease modification limits trial design and intervention comparison. To address this gap, we developed a core outcome set for disease modification in type 2 diabetes through a modified Delphi process conducted according to COMET guidance. Candidate outcomes were identified from the literature and refined by an international multidisciplinary steering group comprising clinicians, researchers, and people living with type 2 diabetes. Across two Delphi rounds involving health-care professionals, researchers, and patients (round one n=233; round two n=79), agreement was reached for 35 outcomes spanning 11 domains. This framework aims to support outcome selection, consistency across trials, comparison of interventions, and evaluation of disease-modifying strategies in type 2 diabetes.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Khunti K, Funnell MP, Highton PJ, et al. Disease modification outcomes in type 2 diabetes: a modified Delphi. Lancet Diabetes Endocrinol. 2026. PMID: 42810354. doi:10.1016/S2213-8587(26)00243-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。